These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 32610327

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy.
    Wood CL, Cheetham TD, Hollingsworth KG, Guglieri M, Ailins-Sahun Y, Punniyakodi S, Mayhew A, Straub V.
    BMC Pediatr; 2019 Apr 25; 19(1):131. PubMed ID: 31023296
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy.
    Tian C, Wong BL, Hornung L, Khoury JC, Miller L, Bange J, Rybalsky I, Rutter MM.
    Neuromuscul Disord; 2016 Nov 25; 26(11):760-767. PubMed ID: 27614576
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bone density and bone health alteration in boys with Duchenne Muscular Dystrophy: a prospective observational study.
    Suthar R, Reddy BVC, Malviya M, Sirari T, Attri SV, Patial A, Tageja M, Didwal G, Khandelwal NK, Saini AG, Saini L, Sahu JK, Dayal D, Sankhyan N.
    J Pediatr Endocrinol Metab; 2021 May 26; 34(5):573-581. PubMed ID: 33838091
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy.
    Sbrocchi AM, Rauch F, Jacob P, McCormick A, McMillan HJ, Matzinger MA, Ward LM.
    Osteoporos Int; 2012 Nov 26; 23(11):2703-11. PubMed ID: 22297733
    [Abstract] [Full Text] [Related]

  • 15. Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates.
    Catalano A, Vita GL, Bellone F, Sframeli M, Distefano MG, La Rosa M, Gaudio A, Vita G, Morabito N, Messina S.
    J Endocrinol Invest; 2022 Mar 26; 45(3):517-525. PubMed ID: 34524678
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of Neridronate in the Management of Bone Loss in Patients with Duchenne Muscular Dystrophy: Results from a Pilot Study.
    Moretti A, Liguori S, Paoletta M, Gimigliano F, Iolascon G.
    Adv Ther; 2022 Jul 26; 39(7):3308-3315. PubMed ID: 35614293
    [Abstract] [Full Text] [Related]

  • 17. Reduced bone mineral density in adolescents with Duchenne Muscular Dystrophy (DMD) and scoliosis.
    Tsaknakis K, Jäckle K, Lüders KA, Lorenz HM, Braunschweig L, Hell AK.
    Osteoporos Int; 2022 Sep 26; 33(9):2011-2018. PubMed ID: 35583603
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone and testosterone delay vertebral fractures in boys with muscular dystrophy on chronic glucocorticoids.
    Loscalzo E, See J, Bharill S, Yousefzadeh N, Gough E, Wu M, Crane JL.
    Osteoporos Int; 2024 Feb 26; 35(2):327-338. PubMed ID: 37872346
    [Abstract] [Full Text] [Related]

  • 19. Randomized Controlled Trial Evaluating the Use of Zoledronic Acid in Duchenne Muscular Dystrophy.
    Zacharin M, Lim A, Gryllakis J, Siafarikas A, Jefferies C, Briody J, Heather N, Pitkin J, Emmanuel J, Lee KJ, Wang X, Simm PJ, Munns CF.
    J Clin Endocrinol Metab; 2021 Jul 13; 106(8):2328-2342. PubMed ID: 33954789
    [Abstract] [Full Text] [Related]

  • 20. The impact of testosterone therapy on quality of life in adolescents with Duchenne muscular dystrophy.
    Wood CL, Page J, Foggin J, Guglieri M, Straub V, Cheetham TD.
    Neuromuscul Disord; 2021 Dec 13; 31(12):1259-1265. PubMed ID: 34702655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.